Van Eck Associates Corp Glaukos Corp Transaction History
Van Eck Associates Corp
- $80.1 Billion
- Q3 2024
A detailed history of Van Eck Associates Corp transactions in Glaukos Corp stock. As of the latest transaction made, Van Eck Associates Corp holds 1,215 shares of GKOS stock, worth $171,849. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,215
Previous 1,457
16.61%
Holding current value
$171,849
Previous $172,000
8.14%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding GKOS
# of Institutions
340Shares Held
47.1MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.14 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$831 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$309 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$276 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$232 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.73B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...